European neuroscience-seventh biennial FENS forum

A. J. Hannan

Research output: Contribution to journalArticlepeer-review

Abstract

The European Neuroscience-Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).

Original languageEnglish
Pages (from-to)607-609
Number of pages3
JournalIDrugs
Volume13
Issue number9
Publication statusPublished - Sep 2010
Externally publishedYes

Fingerprint Dive into the research topics of 'European neuroscience-seventh biennial FENS forum'. Together they form a unique fingerprint.

Cite this